TMPRSS2 and ovarian carcinoma: In our analysis, we found that higher OS and DFS were indicated in the low TMPRSS2 expression group of ovarian cancer relative to the elevated expression group, based on DUKE‐OC, GSE9891 and GSE26712 dataset, but the specific mechanism needs further verification and discussion in the future.